1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-3 of 3 reports

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 88 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia ...

  • World
  • South Africa
  • Drug Development
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Smoking Prevalence

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 75 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney ...

  • World
  • China
  • Chronic Disease
  • Drug Development
  • Industry analysis
  • Patients Undergoing Dialysis
  • Drug Approval

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 90 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 Summary Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma ...

  • World
  • Pharmaceutical
  • Cancer
  • Industry analysis



Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on